{
  "abstract": "Background and Importance Accurate recording of drug hypersensitivities (DHs) is essential for patient safety, yet challenges persist, including incomplete patient health records, lack of standardised terminology coding, and excessive alerts through computerised decision support. Clinical pharmacists share responsibility for managing and documenting DHs, but little is known about their needs and priorities in this role. Understanding their perceptions and workflow is crucial to optimise DH documentation practices, prevent DH reactions, and reduce medication errors.Aim and Objectives To qualitatively explore clinical pharmacists’ perceptions, needs, and experiences regarding DH management and documentation after implementing a structured, coded DH documentation tool in the electronic health record of a university hospital.Material and Methods We conducted a prospective, single-centre study using a generic qualitative research methodology. Clinical pharmacists were recruited via purposeful sampling between December 2024 and February 2025. Semi-structured face-to-face interviews (~1 hour) were conducted following informed consent. Participants were asked about their perceptions of DH management and documentation, workflow, structured tool, and potential improvements. Interviews were audio-recorded, transcribed verbatim, and thematically analysed in NVivo using an inductive, iterative approach, exploring both semantic and latent features within a pragmatic perspective. Ethical approval was obtained from the ethics committee (BUN:B1432024000241).Results Ten clinical pharmacists were interviewed (eight women; mean experience 7.2 years, range: 0-18). Three key themes emerged: (i) Working context: Pharmacists reported encountering DHs during medication validation, consultations, and penicillin de-labelling, emphasising collaboration when problems arose. DH management was expressed as primarily a physician’s responsibility, while nurses should be trained to recognise DHs at bedside. Verification was described as mostly verbal, mainly for high-risk drugs. (ii) Barriers: Participants indicated that time constraints, unclear responsibilities, hesitancy to modify records, and reliance on patient self-reporting could compromise DH documentation accuracy. (iii) Improvement strategies: Pharmacists suggested updating coded terminologies and integrating allergy consult requests in the tool, providing practical, case-based training, establishing clear workflow and referral agreements, and developing context-aware, severity-based decision support with colour coding and de-labelling functionalities.Conclusion and Relevance While comprehensive DH recording requires multidisciplinary effort, clinical pharmacists play a key role in improving accuracy. Addressing persistent barriers through clearer roles, practical training, and digital support tools can enhance DH documentation and reduce medication errors.Conflict of Interest No conflict of interest",
  "authors": [
    {
      "affiliations": [
        "Vrije Universiteit Brussel, Department of Pharmaceutical and Pharmacological Sciences, Brussels, Belgium"
      ],
      "name": "V Shiwa"
    },
    {
      "affiliations": [
        "Vrije Universiteit Brussel, Department of Pharmaceutical and Pharmacological Sciences, Brussels, Belgium"
      ],
      "name": "W El Haddadi"
    },
    {
      "affiliations": [
        "Vrije Universiteit Brussel, Department of Pharmaceutical and Pharmacological Sciences, Brussels, Belgium"
      ],
      "name": "P Cornu"
    }
  ],
  "title": "5PSQ-079 Clinical pharmacists’ perspectives on recording drug hypersensitivities in patient health records: implications for patient safety",
  "uid": "1bfe10e8-cc74-58a3-aa77-f2aa982ad2b4"
}